Italia markets open in 6 hours 8 minutes

Investec Group (INVP.L)

LSE - LSE Prezzo differito. Valuta in GBp (0.01 GBP).
Aggiungi a watchlist
524,00+12,50 (+2,44%)
Alla chiusura: 05:11PM BST
Schermo intero
Chiusura precedente511,50
Aperto0,00
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno0,00 - 0,00
Intervallo di 52 settimane
Volume12
Media Volume951.502
Capitalizzazione3,43B
Beta (5 anni mensile)1,09
Rapporto PE (ttm)7,18
EPS (ttm)0,73
Prossima data utili23 mag 2024
Rendimento e dividendo (futuro)0,33 (6,45%)
Data ex dividendo07 dic 2023
Stima target 1A601,83
  • GlobeNewswire

    Form 8.5 (EPT/RI) - Finsbury Food Group Plc

    FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Finsbury Food Group plc(c) Name of the party to the offer with which exempt principal trader is connected

  • GlobeNewswire

    Form 8.5 (EPT/RI) - Restaurant Group plc

    FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Restaurant Group plc (The)(c) Name of the party to the offer with which exempt principal trader is connec

  • GlobeNewswire

    Form 8.5 (EPT/RI) - Dechra Pharmaceuticals plc

    FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Dechra Pharmaceuticals(c) Name of the party to the offer with which exempt principal trader is connected: